Chronic Liver Disease

Uses

Risks & contraindications

Comparisons

Evidence quality

Highlighted claims

• Patients with IBD and CLD were older on average than those with IBD alone, with mean ages of 50.24 versus 44.45 years. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• In-hospital mortality was nearly three times higher in patients with IBD and CLD than in those with IBD alone (0.77% vs 0.27%). — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Depression and anxiety were more prevalent among patients with both IBD and CLD than among those with IBD alone. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Hispanic patients had a 1.31-fold higher prevalence of CLD within the IBD cohort. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• 4.11% of hospitalised adults with IBD had a secondary diagnosis of chronic liver disease. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• Prior studies have shown a 33% higher risk of CLD and a 35% increased risk of advanced fibrosis in the lowest income group compared with the highest. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample